Figure 7From: Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity Chemosensitivity by MTS assay. PC-3M cells with CD44v7-10 RNAi were maximally sensitive to Docetaxel doses up to 50 nM. Moderate increases in sensitivity were noted after re-expression of CD44s as a Separate or Fusion protein. * indicates p < 0.05. As a control, benign BPH-1 prostate cells were also highly sensitive.Back to article page